Dr SHANE RETI (Deputy Leader—National): Thank you, Madam Speaker. It's a pleasure to take a short call on this bill, which we are clearly supporting. And just to remind ourselves—we find ourselves in this situation because, as compared to other countries, we don't have an EUA, an emergency use application, which the US and, certainly, the UK and other countries have. So we've had to rely on a section 23, provisional consent. If we imagine the initial intention of an EUA-type procedure, it actually came out of the 1980s with the HIV/AIDS epidemic, where we needed to move really quickly to progress medicines that we believed had core net-benefit over disadvantages. And that whole decade of needing HIV medicines brought us to the 1990s.